Holen Sie sich die Stockscreener-App
1.38
0.00%
0.00
Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
21.54%
17.99
|
22.93 | 22.10 | 30.73 | 22.73 |
| Cost Of Revenue |
6.40%
6.30
|
6.731 | 7.315 | 12.17 | 9.99 |
| Gross Profit |
27.83%
11.69
|
16.20 | 14.78 | 18.56 | 12.74 |
Operating Expenses
|
2.30%
14.16
|
13.84 | 16.29 | 18.39 | 21.30 |
| Benefits Costs and Expenses |
7.57%
20.64
|
22.33 | 30.22 | 33.19 | 29.93 |
| Costs And Expenses |
7.57%
20.64
|
22.33 | 30.22 | 33.19 | 29.93 |
| Depreciation and Amortization |
3.42%
1.834
|
1.899 | 1.941 | - | - |
| Operating Income/Loss |
204.23%
-2.464
|
2.364 | -1.504 | 0.169 | -8.558 |
| Income/Loss From Continuing Operations Before Tax |
534.54%
-2.642
|
0.608 | -8.12 | -2.457 | -7.20 |
| Income Tax Expense/Benefit |
70.41%
0.245
|
0.828 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1,212%
-2.887
|
-0.22 | -8.12 | -2.457 | -7.20 |
|
Net Income/Loss
|
1,212%
-2.887
|
-0.22 | -8.12 | -2.457 | -7.20 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.29%
5.5336
|
5.5177 | 5.482 | 0.2408 | 3.7268 |
| Basic Earnings Per Share |
1,200%
-0.52
|
-0.04 | -1.48 | -0.40 | -1.93 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):